Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: Results at one year.

[1]  K. McVary,et al.  Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia , 2019, Prostate Cancer and Prostatic Diseases.

[2]  K. Zorn,et al.  The Rezūm system - a minimally invasive water vapor thermal therapy for obstructive benign prostatic hyperplasia. , 2019, The Canadian journal of urology.

[3]  C. Roehrborn,et al.  Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study. , 2019, Urology.

[4]  K. McVary,et al.  Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia? , 2018, The journal of sexual medicine.

[5]  G. Robert,et al.  [Surgical treatment of BPO: Standard and innovations]. , 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[6]  R. Light,et al.  Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia , 2017, Research and reports in urology.

[7]  C. Roehrborn,et al.  Convective Thermal Therapy: Durable 2‐Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia , 2017, The Journal of urology.

[8]  C. Roehrborn,et al.  Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study. , 2016, The journal of sexual medicine.

[9]  C. Roehrborn,et al.  Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. , 2016, The Journal of urology.

[10]  G. Muir,et al.  Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men's ejaculatory function: Time for a bespoke approach? , 2016, International journal of urology : official journal of the Japanese Urological Association.

[11]  D. Pacík,et al.  Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. , 2015, Urology.

[12]  R. Robb,et al.  Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Validation of Convective Thermal Energy Transfer and Characterization With Magnetic Resonance Imaging and 3-Dimensional Renderings. , 2015, Urology.

[13]  M. Oelke,et al.  EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. , 2015, European urology.

[14]  L. Mynderse,et al.  Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm® system: evaluation of acute ablative capabilities in the human prostate , 2015, Research and reports in urology.

[15]  J. Cornu,et al.  [Clinical impact of the intravesical prostatic protrusion: a review by the LUTS committee of the French Urological Association]. , 2014, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[16]  E. Vicaut,et al.  Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study. , 2013, European urology.

[17]  C. Roehrborn,et al.  The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. , 2010, European urology.

[18]  M. Barry,et al.  Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? , 1995, The Journal of urology.